Evidence map›Paper›PMID 41662264›Full record

ArticlePloS one2026

Feasibility and testing outcomes of task-shared implementation of advanced HIV disease point of care tests in Beira (Mozambique) and Kinshasa (DRC).

Zibusiso Ndlovu, Ruvimbo Nhandara, Kiyara Govender, Fingani Mpande-Nyasulu, Emmanuel Kabwe, Antonio Flores, Calorine Mekiedje, Laban Kyembe, Christine Bimansha, Tania Carmilla Tomas and 13 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Zibusiso NdlovuMedecins Sans Frontières (MSF), Beira, Mozambique.ORCID https://orcid.org/0000-0003-0386-8641
Ruvimbo NhandaraSouthern African Medical Units (SAMU), Medecins Sans Frontières, Cape Town, South Africa.
Kiyara GovenderSouthern African Medical Units (SAMU), Medecins Sans Frontières, Cape Town, South Africa.
Fingani Mpande-NyasuluFaculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
Emmanuel KabweKazan (Volga region) Fedaral University, Kazan, Russia.
Antonio FloresSouthern African Medical Units (SAMU), Medecins Sans Frontières, Cape Town, South Africa.
Calorine MekiedjeSouthern African Medical Units (SAMU), Medecins Sans Frontières, Cape Town, South Africa.
Laban KyembeMedecins Sans Frontières (MSF), Beira, Mozambique.
Christine BimanshaMedecins Sans Frontières (MSF), Beira, Mozambique.
Tania Carmilla TomasMedecins Sans Frontières (MSF), Beira, Mozambique.
Leticia PennaMedecins Sans Frontières (MSF), Beira, Mozambique.
Mariana da SilvaMedecins Sans Frontières (MSF), Beira, Mozambique.
Micheque Jose TauroMedecins Sans Frontières (MSF), Beira, Mozambique.
Ana Jossias BondeMedecins Sans Frontières (MSF), Beira, Mozambique.
Luisa Rita MiguelMedecins Sans Frontières (MSF), Beira, Mozambique.
Pedro David ManussoMinistry of Health Mozambique, Maputo, Mozambique.
Gisele MucinyaMedecins Sans Frontières (MSF), Kinshasa, Democratic Republic of the Congo.
Yvonne NzomukundaMedecins Sans Frontières (MSF), Kinshasa, Democratic Republic of the Congo.
Rollin NdombeMedecins Sans Frontières (MSF), Kinshasa, Democratic Republic of the Congo.
Richard Ingwe ChuyNational HIV/AIDS and STI Control program of the Democratic Republic of the Congo, Kinshasa, Democratic Republic of the Congo.
Aimé MboyoNational HIV/AIDS and STI Control program of the Democratic Republic of the Congo, Kinshasa, Democratic Republic of the Congo.
Tom EllmanSouthern African Medical Units (SAMU), Medecins Sans Frontières, Cape Town, South Africa.
Geoffrey FattiDivision of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-6467-662X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMortality from advanced HIV disease (AHD) remains high and current strategies to promptly test people eligible for AHD screening, are insufficient. Task sharing for point of care (POC) testing utilizing lay health workers (LHW) is recommended, however it is marginally practised in many countries. This study sought to describe the feasibility and testing outcomes of task-shared implementation of the AHD POC diagnostic tests utilizing LHW and professional health care workers (HCW).

methodsThis was a cross-sectional mixed-methods implementation study in seven primary and three secondary health facilities, in Mozambique and Democratic Republic of Congo (DRC). From March to November 2022, consenting HIV positive adults eligible for AHD screening, were offered Visitect CD4 lateral flow assay (LFA), and or subsequently urinary Mycobacterium tuberculosis lipoarabinomannan antigen (TB LAM) and cryptococcal antigen (CrAg) tests. The primary study outcome was the proportion of testers (LHW and HCW) who found it 'easy' to integrate the 3 POC tests within their routine work together with their opinions on the value of task shared AHD POC testing.

resultsA total of 1542 patients were screened for AHD by 35 LHW (34 counsellors, and 1 lay educator) and 45 professional HCW (28 nurses and 9 clinical officers and 8 doctors). In the study period, LHW conducted a median number of 27 [IQR: 16-34] Visitect CD4 LFA tests, whereas nurses, clinical officers together with doctors conducted 19 and 11 respectively. Visitect CD4 LFA increased CD4 testing by 10.7% in Munhava (Beira) and 22.9% in CHK (DRC), complementing existing CD4 testing instruments. Among testers who completed the feasibility survey, nearly sixty percent of testers (25/42; LHW in particular) found it easy to integrate AHD POC testing within their routine workflow. The prevalence of AHD was 39.2% (604/1542). A total of 34% (146/430) and 5.4% (22/407) of patients tested positive for urine TB LAM and plasma CrAg respectively. Of these, 82.2% (120/146) and 36.4% (8/22) had a documented therapeutic intervention. The median time for completing the Visitect CD4 LFA and conveying the results to the clinician was 59 minutes [IQR: 48-71].

conclusionTask-shared integrated testing for AHD at POC among LHW and professional HCW, is feasible and can improve access to AHD testing. However, as POC testing responsibilities become shared, documentation of testing activities could increase in complexity and can be easily fragmented, especially when there is limited supervision. Nevertheless, LHW are well suited for POC testing due to limited availability and higher clinical workload of other HCW.

Indexed as

HIV InfectionsPoint-of-Care TestingAdultCross-Sectional StudiesDemocratic Republic of the CongoFeasibility StudiesFemaleHealth PersonnelHumansMaleMiddle AgedMozambiqueRapid Diagnostic TestsTask Shifting

Identifiers

PMID41662264
PMCPMC12885292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.